Sign in

CIK 0001789972 · Non-accelerated filer<br>Smaller reporting company

Cullinan Therapeutics, Inc.

Sign in to watch
Ticker
CGEM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
813879991
Phone
617-410-4650
Business address
ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
Former names
Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
  1. 10-K Report Annual Report
  2. 8-K Event Results of operations
  3. 4 Grant or award President and CEO acquired 109,000 shares (grant or award)
  4. 4 Grant or award Chief Financial Officer acquired 47,000 shares (grant or award)
  5. 4 Grant or award Chief Business Officer acquired 20,500 shares (grant or award)
  6. 4 Grant or award Chief Legal Officer acquired 47,000 shares (grant or award)
  7. 4 Grant or award Chief Scientific Officer acquired 38,500 shares (grant or award)
  8. 4 Grant or award Chief Development Officer acquired 38,500 shares (grant or award)
  9. 4 Grant or award Chief Medical Officer acquired 60,000 shares (grant or award)
  10. SC 13G/A Stake Amended Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. 8-K Event Material agreement · Results of operations · Regulation FD disclosure
  13. SC 13G/A Stake Amended Statement of Ownership
  14. 5 Insider Annual Insider Trading Report
  15. SC 13G/A Stake Amended Statement of Ownership
  16. SC 13G Stake Amended Statement of Ownership
  17. 4 Other disposition 10% owner disposed of 6,400,000 shares (other)
  18. 8-K Event Unregistered share sale · Bylaws or fiscal year change
  19. 4 Grant or award Chief Financial Officer acquired 201 shares (grant or award)
  20. 4 Open-market sale See Remarks sold 4,000 shares at $13.30 ($53,200)

Page 15 of 24 · 471 filings